Artemis Medicare Services Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has delivered good profit growth of 70.9% CAGR over last 5 years
- Latest quarter profit grew 45.0% YoY, showing strong momentum
- Company has delivered good sales growth of 21.4% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.64x)
- Operating margins have improved to 17.5% from 14.1%
CONS
- Promoter holding has decreased over last 2 years: -9.1pp
- Equity base is being diluted - shares outstanding up 18.0%
- Growth is decelerating - 3Y profit CAGR (37.6%) trails the 5Y trend (70.9%)
- Though reporting repeated profits, the company pays out little dividend (6.9%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8850.00 | 60.90 | 127249.42 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1037.20 | 69.29 | 100951.74 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 716.15 | 105.57 | 94200.74 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 887.30 | 63.93 | 66987.44 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 762.95 | 208.69 | 66504.25 | 0.39 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.26 | 19.53 |
| MEDANTA | 1447.55 | 69.98 | 38920.53 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1867.35 | 46.76 | 38161.31 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 768.85 | 158.06 | 32292.20 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1909.40 | 59.14 | 32049.05 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 507.00 | 108.33 | 16073.23 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1502.30 | 82.53 | 15473.35 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| ARTEMISMED | 344.40 | 47.97 | 5452.07 | 0.13 | 31.44 | 48.33 | 287.32 | 12.69 | 15.83 | 19.64 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 217 | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 | 282 | |
| 174 | 184 | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 | 245 | |
| Operating Profit | 27 | 33 | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 | 37 |
| OPM % | 13.55% | 15.36% | 15.08% | 16.65% | 16.45% | 17.80% | 16.23% | 15.14% | 16.37% | 18.59% | 16.40% | 18.37% | 13.02% |
| 1 | 2 | 2 | 2 | 4 | 8 | 9 | 12 | 7 | 8 | 4 | 8 | 5 | |
| Interest | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 |
| Depreciation | 9 | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 |
| Profit before Tax | 13 | 19 | 16 | 19 | 22 | 31 | 27 | 29 | 30 | 40 | 30 | 39 | 42 |
| Tax % | 25.77% | 27.30% | 29.19% | 28.40% | 23.58% | 27.41% | 23.15% | 19.97% | 28.77% | 24.64% | 23.88% | 24.77% | 26.26% |
| Net Profit | 10 | 14 | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 | 31 |
| 0.73 | 1.01 | 0.85 | 1.02 | 1.16 | 1.44 | 1.33 | 1.48 | 1.36 | 1.90 | 1.42 | 1.87 | 1.96 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 459 | 503 | 547 | 563 | 402 | 545 | 714 | 845 | 913 | 1,060 | 1,093 | |
| 407 | 443 | 482 | 501 | 367 | 479 | 621 | 717 | 763 | 875 | 912 | |
| Operating Profit | 52 | 59 | 64 | 62 | 35 | 66 | 94 | 128 | 150 | 185 | 181 |
| OPM % | 11.30% | 11.83% | 11.73% | 11.05% | 8.72% | 12.14% | 13.13% | 15.19% | 16.41% | 17.46% | 16.56% |
| 5 | 4 | 4 | 5 | 7 | 5 | 7 | 7 | 33 | 27 | 25 | |
| Interest | 9 | 9 | 11 | 13 | 12 | 11 | 19 | 30 | 30 | 27 | 26 |
| Depreciation | 15 | 18 | 20 | 22 | 21 | 21 | 29 | 38 | 43 | 46 | 48 |
| Profit before Tax | 32 | 35 | 37 | 32 | 9 | 39 | 53 | 68 | 109 | 139 | 151 |
| Tax % | 16.45% | 24.52% | 44.16% | 36.09% | 20.42% | 16.06% | 24.93% | 27.77% | 23.61% | 25.41% | 24.98% |
| Net Profit | 27 | 27 | 21 | 20 | 7 | 33 | 40 | 49 | 83 | 103 | 113 |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 5.35 | 2.34 | 2.86 | 3.62 | 6.07 | 6.53 | — |
| Dividend Payout % | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 15.21% | 12.44% | 7.42% | 6.89% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 10%
- 5 Years:
- 21%
- 3 Years:
- 14%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 17%
- 5 Years:
- 71%
- 3 Years:
- 38%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 57%
- 3 Years:
- 39%
- 1 Year:
- 44%
RETURN ON EQUITY
- 10 Years:
- 13%
- 5 Years:
- 13%
- 3 Years:
- 14%
- Last Year:
- 13%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 0 | 13 | 13 | 13 | 13 | 14 | 14 | 16 |
| 183 | 210 | 280 | 301 | 308 | 341 | 385 | 432 | 824 | 923 | |
| 93 | 90 | 114 | 107 | 134 | 188 | 263 | 275 | 249 | 221 | |
| Trade Payables | 62 | 67 | 74 | 74 | 56 | 58 | 83 | 89 | 97 | 96 |
| 63 | 63 | 87 | 86 | 86 | 114 | 162 | 169 | 201 | 247 | |
| Total Liabilities | 422 | 452 | 555 | 581 | 597 | 713 | 907 | 978 | 1,385 | 1,503 |
| 283 | 309 | 381 | 387 | 372 | 476 | 584 | 699 | 729 | 790 | |
| Capital Work in Progress | 27 | 43 | 49 | 56 | 81 | 62 | 95 | 33 | 39 | 32 |
| 0 | 0 | 0 | 2 | 4 | 6 | 12 | 15 | 15 | 15 | |
| 6 | 6 | 7 | 11 | 9 | 12 | 13 | 9 | 9 | 13 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83 | 93 | 111 | |
| Cash & Bank | 10 | 12 | 12 | 15 | 29 | 27 | 48 | 58 | 393 | 206 |
| 96 | 82 | 105 | 111 | 102 | 131 | 156 | 80 | 107 | 335 | |
| Total Assets | 422 | 452 | 555 | 581 | 597 | 713 | 907 | 978 | 1,385 | 1,503 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 59 | 73 | 50 | 61 | 29 | 77 | 132 | 108 | 150 | 129 | |
| Cash from Investing | -74 | -67 | -50 | -22 | -34 | -106 | -153 | -90 | -396 | -96 |
| Cash from Financing | 19 | -10 | 14 | -33 | 13 | 44 | 30 | -26 | 274 | -41 |
| 3 | -4 | 5 | 2 | 6 | -2 | 7 | -8 | 28 | -8 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-08 - Artemis Medicare Services Limited has informed the Exchange about Analysts/ Institutional Investors Conference - September 22, 2026
2026-08-27 - Artemis Medicare Services Limited has informed the Exchange about Analysts/ Institutional Investors' Conference - September 3, 2026
2026-08-10 - Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q1 FY27
2026-08-10 - Artemis Medicare Services Limited has informed the Exchange about Analysts/ Institutional Investors' Conference - August 13, 2026
2026-08-04 - Artemis Medicare Services Limited has informed the Exchange about Audio Recording of Earnings Conference Call - Q1 FY27
2026-08-04 - Artemis Medicare Services Limited has informed the Exchange about Copy of Newspaper Publication - August 4, 2026
2026-08-03 - Monitoring Agency Report for the quarter ended June 30, 2026
2026-08-03 - Artemis Medicare Services Limited has informed the Exchange regarding a press release dated August 03, 2026, titled "Artemis Consolidated Revenue from Operations up 12.7% in Q1 FY27 (YoY); EBITDA up 27.9%; Profit up 48.3%".
2026-08-03 - Artemis Medicare Services Limited has informed the Exchange about Investor Presentation
News
Recent coverage and analyst commentary for ARTEMISMED
Loading news…
AI Stock Analyst
Artemis Medicare Services Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account